Home Healthcare Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Global home healthcare market size is projected to reach USD 297.5 billion by 2030 from USD 171.9 billion in 2020, at a CAGR of 7.6% during the forecast period.

Clear

Description

Home Healthcare Market by Product (Dialysis Equipment, Ventilators, ECG, Canes, Wheelchairs, Activity Monitors, Nebulizers, BP Monitors), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication, Region – Global Forecast to 2025
Product Overview
Monitoring and diagnostic devices are available in almost every home, from basic health care equipment such as thermometers and weight scales to specialized devices such as blood pressure monitors, glucometers, INR meters, pulse oximeters, peak flowmeters, EEGs, or portable EKG/pulse meters. Most of these monitoring and diagnostic devices are available at pharmacies and usually can be bought over the counter or even via the Internet.
Market Overview
Global home healthcare market size is projected to reach USD 297.5 billion by 2030 from USD 171.9 billion in 2020, at a CAGR of 7.6% during the forecast period. Rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home care devices.
COVID-19 impact on the home healthcare market
The COVID-19 pandemic has a mixed impact on the home healthcare market. As the home healthcare market consists of products and services, both have different effects. COVID-19 would positively impact few home healthcare monitoring products such as blood glucose monitors, blood pressure monitors, pulse oximeters, and temperature monitors.
Global Home Healthcare Market Dynamics
DRIVER: Rising aging population, high incidence of chronic diseases, and need to expand home healthcare access
The growth of the aging population segment will boost the demand for healthcare and significantly increase the burden on governments and health systems as the aging population is more prone to chronic diseases. This will prove favorable to the market for home healthcare, which can enhance the overall reach of and access to healthcare while reducing unnecessary visits, hospital admissions & readmissions, and the time and costs involved in traveling to meet healthcare professionals.
RESTRAINT: Patient safety concerns
In home care, the nurse-physician association involves lesser face-to-face contact, and the nurse is responsible for making assessments and communicating findings. This factor affects the degree of patient safety and outcomes. Another distinguishing characteristic of home healthcare is that clinicians offer medical care to each patient in a unique setting.
OPPORTUNITY: Untapped developing regions
Home healthcare is an established trend in the developed regions of North America and Europe. Due to favorable regulations and policies in these regions, homecare is rapidly being adopted. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.
CHALLENGE: Shortage of home care workers
Home healthcare is a booming market, with increasing demand for home care providers/workers. According to the employment projections of the US Bureau of Labor Statistics, during 2014-2024, home healthcare occupations such as personal care aides and home health aides ranked among the top 10 in the list.

The skilled nursing care services segment dominated the home healthcare services market in 2019.
Based on services, the global home healthcare market is segmented into rehabilitation services, infusion therapy services, unskilled care services, respiratory therapy services, pregnancy care services, skilled nursing services, and hospice and palliative care services. Skilled nursing services accounted for the largest share of the home healthcare services market in 2019. Skilled medical care in home settings can provide a comforting solution over residing in a hospital, nursing home, or an assisted living community. The favorable insurance coverage for skilled nursing services is expected to support the growth of this market during the forecast period.
North America was the largest regional market for home healthcare in 2019.
The home healthcare market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. The large share of North America in the global market is attributed to the rising prevalence of chronic conditions, high healthcare expenditure, high disposable income, the increasing overall geriatric population, high disposable income, and superior healthcare infrastructure.
Key Market Players
The prominent players operating in this market include Fresenius SE & Co. KGaA (Germany), GE Healthcare (US), Linde plc (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Amedisys (US), Kindred at Home (US), and LHC Group, Inc. (US)
By Product
• Testing, Screening, & Monitoring Products
o Blood Glucose Monitors
o Blood Pressure Monitors
o Pulse Oximeters
o Peak Flow Meters
o Heart Rate Monitors
o Fetal Monitoring Devices
o HIV Test Kits
o Home Sleep Testing Devices
o Coagulation Monitoring Products
o Ovulation and Pregnancy Test Kits
o Holter and Event Monitors
o Cholesterol Monitoring Devices
o Colon Cancer Test Kits
o Home Hemoglobin A1c Test Kits
o Drug and Alcohol Test Kits
o ECG/EKG Devices
o EEG Devices
o Temperature Monitors
o Hearing Aids
o Activity Monitors & Wristbands
• Therapeutic Products
o Oxygen Delivery Systems
o Nebulizers
o Ventilators
o Sleep Apnea Therapeutic Devices
o Wound Care Products
o IV Equipment
o Dialysis Equipment
o Insulin Delivery Devices
o Inhalers
o Other Therapeutic Products (ostomy devices, automated external defibrillators (AEDs))
• Mobility Care Products
o Wheelchairs
o Walkers & Rollators
o Mobility Scooters
o Canes
o Crutches
By Service
• Skilled Nursing Services
• Rehabilitation Therapy Services
• Hospice and Palliative Care Services
• Unskilled Care Services
• Respiratory Therapy Services
• Infusion Therapy Services
• Pregnancy Care Services
By Indication
• Cardiovascular Disorders & Hypertension
• Diabetes
• Respiratory Diseases
• Pregnancy
• Mobility Disorders
• Hearing Disorders
• Cancer
Wound Care
• Other Indications

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Global Home Healthcare Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Home Healthcare Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Home Healthcare Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Home Healthcare Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Testing, Screening, & Monitoring Products, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Therapeutic Products, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Mobility Care Products, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Service: Market Share (2020-2030F)
12.3.1. Skilled Nursing Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Rehabilitation Therapy Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Hospice and Palliative Care Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Unskilled Care Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Respiratory Therapy Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Infusion Therapy Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Pregnancy Care Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Indication: Market Share (2020-2030F)
12.4.1. Cardiovascular Disorders & Hypertension, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Diabetes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Respiratory Diseases, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Pregnancy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.5. Mobility Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.6. Hearing Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.7. Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.8. Wound Care, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.9. Other Indications, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13 Company Profile
13.1. Fresenius SE & Co. KGaA (Germany)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. GE Healthcare (US)
13.3. Linde plc (Ireland)
13.4. F. Hoffmann-La Roche Ltd (Switzerland)
13.5. A&D Company (Japan)
13.6. BAYADA Home Health Care (US)
13.7. Invacare Corporation (US)
13.8. Abbott (US)
13.9. Amedisys (US)
13.10. Kindred at Home (US)
13.11. LHC Group, Inc. (US)
13.12. OMRON Corporation (Japan)
13.13. Koninklijke Philips N.V. (Netherlands)
13.14. Drive DeVilbiss Healthcare (US)
13.15. Hamilton Medical (Switzerland)
13.16. Other Prominent Players

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

RSS
Follow by Email